Grandis Appointed as New CTSI Director, Associate Vice Chancellor of Clinical & Translational Research

Jennifer R. Grandis, MD

Announcement via UCSF.edu

Jennifer R. Grandis, MD, has been appointed UC San Francisco's Associate Vice Chancellor of Clinical and Translational Research (AVC-CTR) on Oct. 6. She will begin her new post in January 2015 while also holding a faculty appointment as professor of Otolaryngology-Head and Neck Surgery.

“I am excited by the opportunity to join the UCSF community and work with faculty, trainees and staff to achieve the promise of clinical and translational medicine,” Grandis said.

This is a critical role for UCSF given today’s rapidly changing landscape of research and patient care that requires the university to have a comprehensive and robust translational and clinical research infrastructure that supports the research and clinical needs of the future.

“Jennifer will lead, manage and shape the strategic direction for broad elements of our clinical and translational research enterprise including the Clinical & Translational Institute (CTSI),” said Executive Vice Chancellor and Provost Jeffrey A. Bluestone, PhD. “In addition, her responsibilities include serving as a liaison to national committees in the field and overseeing  all aspects of clinical trials infrastructure and processes. Jennifer will be collaborating with multiple entities and other leaders on campus, including but not limited to, the Medical Center, the entire EVCP organization, the four Schools and Graduate Division, and key ORUs and centers on campus.”

Grandis will take over for Deborah Grady, MD, who served as the interim director of Clinical and Translational Science Institute (CTSI).

“I am deeply grateful to Deborah for her outstanding job after Clay Johnston’s departure,” Bluestone said. “She has continued the exciting work of CTSI during this transition period and is an incredible asset not only to CTSI but to the entire University. Jennifer and I will continue to count on her wise counsel and commitment to the Clinical & Translational enterprise at UCSF.”

Read the full announcement here

Letter from Executive Vice Chancellor and Provost - Jeffrey A. Bluestone, PhD